Vous êtes ici: Home > Therapeutics (ancienne) > Future of Cannabis and Cannabinoids in Therapeutics

J Cannabis Ther 2003(3/4):163-174

Review and Outlook

Future of Cannabis and Cannabinoids in Therapeutics

Author
E. Russo

Abstract
This study reviews human clinical experience to date with several synthetic cannabinoids, including nabilone, levonantradol, ajulemic acid (CT3), dexanabinol (HU-211), HU-308, and SR141716 (Rimonabant®). Additionally, the concept of "clinical endogenous cannabinoid deficiency" is explored as a possible factor in migraine, idiopathic bowel disease, fibromyalgia and other clinical pain states. The concept of analgesic synergy of cannabinoids and opioids is addressed. A cannabinoid-mediated improvement in night vision at the retinal level is discussed, as well as its potential application to treatment of retinitis pigmentosa and other conditions. Additionally noted is the role of cannabinoid treatment in neuroprotection and its application to closed head injury, cerebrovascular accidents, and CNS degenerative diseases including Alzheimer, Huntington, Parkinson diseases and ALS. Excellent clinical results employing cannabis based medicine extracts (CBME) in spasticity and spasms of MS suggests extension of such treatment to other spasmodic and dystonic conditions. Finally, controversial areas of cannabinoid treatment in obstetrics, gynecology and pediatrics are addressed along with a rationale for such interventions.


Keywords
Nabilone, levonantradol, ajulemic acid, dexanabinol, HU-308, SR141716, cannabis, medical marijuana, migraine, idiopathic bowel disease, fibromyalgia, night vision, retinitis pigmentosa, neuroprotection, dystonia, obstetrics, gynecology, pediatrics

Texte intégral au format PDF ]

Events Online Gratuits

Vous pouvez trouver toutes les informations ici.

L'IACM organise une série de webinaires gratuits et une réunion d'anniversaire en ligne gratuite d'octobre à décembre 2020.

Tous les webinaires se dérouleront en anglais et seront sous-titrés en allemand, français, espagnol et portugais. Tous les webinaires seront disponibles en ligne jusqu'en mars 2021.

La réunion en ligne pour célébrer le 20e anniversaire de l'IACM et pour honorer le 90e anniversaire de Raphael Mechoulam sera une session en direct seulement le 5 novembre 2020.

Les intervenants de la série de webinaires sont Donald I. Abrams, Bonni Goldstein, Franjo Grotenhermen, Manuel Guzmán, Raphael Mechoulam, Kirsten Müller-Vahl, Roger Pertwee, Daniele Piomelli et Ethan Russo.

Vous pouvez trouver toutes les informations ici.

 

IACM Conference 2021

La 12eme Conférence de l'IACM sur les cannabinoïdes en médecine se tiendra à Bâle, en Suisse, du 14 au 16 octobre 2021.

Members only

Regular members can sign up for the new member area of the IACM to access exclusive content.

You need to become a regular member of the IACM to access the new member area.

IACM on Twitter

Follow us on twitter @IACM_Bulletin where you can send us inquiries and receive updates on research studies and news articles.